What Will Happen to STAAR Surgical Company (STAA) Next? The Stock Just Reaches 52-Week High

May 17, 2018 - By Ann Prendergast

STAAR Surgical Company (NASDAQ:STAA) Logo

Investors sentiment decreased to 1.79 in 2017 Q4. Its down 0.07, from 1.86 in 2017Q3. It fall, as 6 investors sold STAAR Surgical Company shares while 23 reduced holdings. 20 funds opened positions while 32 raised stakes. 31.89 million shares or 0.95% more from 31.59 million shares in 2017Q3 were reported.
23,021 are owned by Gsa Ptnrs Ltd Liability Partnership. Alliancebernstein Ltd Partnership reported 0% in STAAR Surgical Company (NASDAQ:STAA). Moreover, Williams Jones & Associates Ltd Liability Co has 0.01% invested in STAAR Surgical Company (NASDAQ:STAA). Tiaa Cref Invest Mngmt Limited Company invested in 147,516 shares. Royal Retail Bank Of Canada holds 642 shares or 0% of its portfolio. Great West Life Assurance Can reported 5,357 shares stake. Century Cos Incorporated owns 33,747 shares. Vanguard Gp Inc invested in 1.34 million shares or 0% of the stock. Credit Suisse Ag has invested 0% in STAAR Surgical Company (NASDAQ:STAA). King Luther Capital Management Corp stated it has 0% in STAAR Surgical Company (NASDAQ:STAA). Moreover, D E Shaw & Communication Inc has 0% invested in STAAR Surgical Company (NASDAQ:STAA) for 39,343 shares. Prelude Cap Management Ltd Company reported 0% stake. 792,407 are owned by Baillie Gifford Company. Rhenman And Ptnrs Asset has 0.16% invested in STAAR Surgical Company (NASDAQ:STAA) for 76,256 shares. Federated Invsts Pa reported 1,043 shares or 0% of all its holdings.

Since March 19, 2018, it had 0 buys, and 6 sales for $451,179 activity. 1,458 shares were sold by Holliday Keith, worth $23,401. Mason Caren L had sold 6,667 shares worth $107,272 on Monday, March 19. The insider Gesten Samuel J sold $45,470.

The stock of STAAR Surgical Company (NASDAQ:STAA) hit a new 52-week high and has $27.46 target or 5.00 % above today’s $26.15 share price. The 5 months bullish chart indicates low risk for the $1.09 billion company. The 1-year high was reported on May, 17 by Barchart.com. If the $27.46 price target is reached, the company will be worth $54.40 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 1.95% or $0.5 during the last trading session, reaching $26.15. About 475,586 shares traded or 87.49% up from the average. STAAR Surgical Company (NASDAQ:STAA) has risen 52.85% since May 17, 2017 and is uptrending. It has outperformed by 41.30% the S&P500.

Analysts await STAAR Surgical Company (NASDAQ:STAA) to report earnings on August, 1. They expect $0.01 EPS, up 200.00 % or $0.02 from last year’s $-0.01 per share. STAA’s profit will be $416,061 for 653.75 P/E if the $0.01 EPS becomes a reality. After $0.04 actual EPS reported by STAAR Surgical Company for the previous quarter, Wall Street now forecasts -75.00 % negative EPS growth.

STAAR Surgical Company (NASDAQ:STAA) Ratings Coverage

Among 4 analysts covering Staar Surgical Company (NASDAQ:STAA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Staar Surgical Company had 6 analyst reports since November 20, 2017 according to SRatingsIntel. The stock of STAAR Surgical Company (NASDAQ:STAA) earned “Outperform” rating by William Blair on Monday, April 30. Canaccord Genuity maintained STAAR Surgical Company (NASDAQ:STAA) on Tuesday, April 24 with “Buy” rating. The firm has “Buy” rating given on Monday, November 20 by Benchmark. The firm has “Hold” rating given on Thursday, March 1 by Stephens. The rating was upgraded by Stephens to “Overweight” on Thursday, May 3. As per Thursday, May 3, the company rating was maintained by Canaccord Genuity.

More recent STAAR Surgical Company (NASDAQ:STAA) news were published by: Seekingalpha.com which released: “STAAR Surgical shoots 21% post Q1 results” on May 03, 2018. Also Nasdaq.com published the news titled: “3 Healthcare Stocks That Soared This Week: Are They Buys?” on May 05, 2018. Nasdaq.com‘s news article titled: “Mid-Day Market Update: Dow Down Over 250 Points; STAAR Surgical Shares Spike Higher” with publication date: May 03, 2018 was also an interesting one.

STAAR Surgical Company, together with its subsidiaries, designs, develops, makes, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company has market cap of $1.09 billion. The firm provides Visian implantable collamer lenses to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It currently has negative earnings. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.

STAAR Surgical Company (NASDAQ:STAA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: